Use of hemopoietic stem cell mobilizer in preparation of medicine for treating diabetes

A technology for hematopoietic stem cells and diabetes drugs, which is applied in the field of preparing drugs for treating diabetes, can solve the problems of difficulty in bone marrow cells, the danger of type I diabetes, etc., and achieves the effects of strong proliferation ability and high safety.

Inactive Publication Date: 2005-03-09
PEKING UNIV
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, there is still a certain distance between these research results and clinical application. Recipients of bone marrow transplantation need to undergo high doses of radiotherapy and chemotherapy, which is extremely dangerous for people with type 1 diabetes
Also, finding enough bone marrow cells to match the tissue type remains very difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0023] 1. Preparation of diabetes model:

[0024] C57 mice, weighing 18-22 grams, were intraperitoneally injected with STZ (streptozotocin) at a dose of 35 mg / kg for five consecutive days.

[0025] 2. Hematopoietic mobilization:

[0026] Control group: inject normal saline.

[0027] Experimental group: From the tenth day of STZ injection, recombinant human granulocyte colony-stimulating factor (G-CSF) was subcutaneously injected at a dose of 200 vg / kg / day. Use it for five days.

[0028] 3. Conclusion:

[0029] Through the use of hematopoietic stem cell mobilization technology, a large number of hematopoietic stem cells in the bone marrow of diabetic animal models are released into the peripheral blood, so that these hematopoietic stem cells participate in the repair of pancreatic endocrine cells, thereby achieving the effect of reversing diabetes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An application of hemopoietic stem cells mobilizing agents including cell factor, especially the granulocyte colony simulating factor, in preparing the medicine for treating diabetes is disclosed.

Description

Technical field: [0001] The present invention relates to the application of hematopoietic stem cell mobilization agent, in particular to the application of preparing medicine for treating diabetes. Background technique: [0002] The treatment of diabetes (Diabetes Mellitus, DM) is one of the important contents of current medical research. In order to treat both symptoms and root causes, pancreas transplantation therapy has been developed rapidly in the past 30 years. But this therapy also has many problems. On the one hand, the source of donor pancreas is very tight and cannot meet the needs at all; on the other hand, the problem of immune rejection is very prominent, and the risk of large-scale abdominal surgery for diabetic patients is greater than the danger brought by diabetes itself. [0003] Isolation and purification of islets from donor pancreases is much safer than pancreas transplantation, but since enough islets can only be isolated from two donor pancreases for...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/19A61K45/00A61P3/10
Inventor 任立晨侯玲玲滕春波赵东昕丁明孝邓宏魁
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap